Michael Trauner, MD
MOHS-Micrographic Surgery · Oxnard, CANPI 1558460394
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,108 of the $1,283 with a category attached, or 86.4%. It is spread thinly across 17 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $596 and has fallen 96.5% since, to $21 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in CA, where the typical reported total is $2,212.
Across 51 payments — averaging $25.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$274
- Sanofi$252
- Eli Lilly$175
- Johnson & Johnson$86
- Pfizer$71
- Galderma Laboratories, L.p.$71
- plus $355 from 11 others
What the payments were for
- Consulting fees$17514%
- Food & beverage$1,10886%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $274 |
| Sanofi | 11 | $252 |
| Eli Lilly | 1 | $175 |
| Johnson & Johnson | 4 | $86 |
| Pfizer | 3 | $71 |
| Galderma Laboratories, L.p. | 4 | $71 |
| Arcutis Biotherapeutics, Inc. | 3 | $63 |
| LEO Pharma Inc. | 2 | $45 |
| Amgen | 2 | $43 |
| GSK | 2 | $35 |
| Blueprint Medicines Corporation | 1 | $28 |
| UCB, Inc. | 1 | $28 |
| Incyte Corporation | 1 | $26 |
| Biofrontera Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
How this compares
$1,283 in reported general payments places this provider in the 35th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 18 | $91 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Oxnard
- Sarah ArronBurlingame$98K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
- Michael MortazieOrange$29K
- Sumaira AasiStanford$27K
- Andrea WilleySacramento$21K
- Benjamin Kelleyla Jolla$20K
- Frank NoodlemanSaratoga$19K
- Howard FeinRolling Hills Estates$19K
- Joanna ChanLong Beach$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.